Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on February 12, 2009. The report discloses the issuance of a press release regarding financial results for the fiscal quarter ended December 31, 2008.
Key Financial Metrics
The filing text serves as a notification of results and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are contained in the referenced press release (Exhibit 99.1), which is not included in the provided text. Therefore, no specific financial values can be extracted from this document.
Material Changes
The filing does not provide comparative data or details on material changes versus the prior period. It only confirms that results for the quarter ended December 31, 2008, were announced.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. These details are presumed to be in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., as the input metadata incorrectly listed Sonoma Pharmaceuticals, Inc.
- Locate and review Exhibit 99.1 (the press release) to obtain actual revenue, net income, and cash flow figures for the quarter ended December 31, 2008.
- Confirm the fiscal quarter end date is December 31, 2008, to ensure accurate period-over-period comparisons.